Mutation News and Research

RSS
Study identifies novel inhibitors against SARS-CoV-2 main protease

Study identifies novel inhibitors against SARS-CoV-2 main protease

Increased paternal age may give rise to disease in the new generation

Increased paternal age may give rise to disease in the new generation

Hybrid immunity from vaccination and Omicron BA.1 or BA.5 breakthrough infections exhibits cross-reactive efficacy against BA.2.75

Hybrid immunity from vaccination and Omicron BA.1 or BA.5 breakthrough infections exhibits cross-reactive efficacy against BA.2.75

Study confirms the implication of Mib1 mutations in non-compaction cardiomyopathy

Study confirms the implication of Mib1 mutations in non-compaction cardiomyopathy

New analysis finds significant disparities in the treatment of familial hypercholesterolemia

New analysis finds significant disparities in the treatment of familial hypercholesterolemia

Viral whole genome study in the United States identifies ORF-disrupting mutations in monkeypox virus

Viral whole genome study in the United States identifies ORF-disrupting mutations in monkeypox virus

Phylodynamic analysis of the monkeypox virus genome suggests low genetic variation and evolutionary rates

Phylodynamic analysis of the monkeypox virus genome suggests low genetic variation and evolutionary rates

Transcriptomic dysregulation across cerebral cortex in autism spectrum disorder

Transcriptomic dysregulation across cerebral cortex in autism spectrum disorder

Shared genetic effects between the autoimmune disease systemic lupus erythematosus and the clinical consequences of COVID-19

Shared genetic effects between the autoimmune disease systemic lupus erythematosus and the clinical consequences of COVID-19

SARS-CoV-2 Omicron's newest subvariant BQ.1.1 shows extraordinary immune evasion potential against vaccine sera

SARS-CoV-2 Omicron's newest subvariant BQ.1.1 shows extraordinary immune evasion potential against vaccine sera

Study evaluates BA.5-bivalent booster against new Omicron sublineages

Study evaluates BA.5-bivalent booster against new Omicron sublineages

Scientists illuminate the molecular events underlying childhood movement disorder

Scientists illuminate the molecular events underlying childhood movement disorder

New insights into the dynamic inner world of the human immune system

New insights into the dynamic inner world of the human immune system

New method to estimate the contribution of each amino acid residue

New method to estimate the contribution of each amino acid residue

Scientists identify a cryptic SARS-CoV-2 lineage in wastewater

Scientists identify a cryptic SARS-CoV-2 lineage in wastewater

Bivalent mRNA booster broadens humoral immunity against SARS-CoV-2 Omicron subvariants

Bivalent mRNA booster broadens humoral immunity against SARS-CoV-2 Omicron subvariants

Exploring viral loads of SARS-CoV-2 Omicron BA.5 and BA.2 sublineages

Exploring viral loads of SARS-CoV-2 Omicron BA.5 and BA.2 sublineages

WHO’s TAG-VE group present the most recent evidence on Omicron sublineages BQ.1 and XBB

WHO’s TAG-VE group present the most recent evidence on Omicron sublineages BQ.1 and XBB

Hybrid virus particles formed from coinfections exhibit immune evasion and expanded tropism

Hybrid virus particles formed from coinfections exhibit immune evasion and expanded tropism

Study expands breast cancer patient population that can benefit from PARP inhibitors

Study expands breast cancer patient population that can benefit from PARP inhibitors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.